1. Home
  2. NNDM vs TRDA Comparison

NNDM vs TRDA Comparison

Compare NNDM & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nano Dimension Ltd.

NNDM

Nano Dimension Ltd.

HOLD

Current Price

$1.80

Market Cap

361.4M

Sector

Technology

ML Signal

HOLD

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$10.59

Market Cap

386.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNDM
TRDA
Founded
2012
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
361.4M
386.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
NNDM
TRDA
Price
$1.80
$10.59
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$20.00
AVG Volume (30 Days)
2.8M
265.1K
Earning Date
11-19-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$69,663,000.00
$61,520,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.16
P/E Ratio
N/A
N/A
Revenue Growth
26.75
N/A
52 Week Low
$1.31
$4.93
52 Week High
$2.74
$21.79

Technical Indicators

Market Signals
Indicator
NNDM
TRDA
Relative Strength Index (RSI) 60.24 70.75
Support Level $1.43 $9.40
Resistance Level $1.65 $10.75
Average True Range (ATR) 0.08 0.60
MACD 0.02 0.02
Stochastic Oscillator 88.10 78.61

Price Performance

Historical Comparison
NNDM
TRDA

About NNDM Nano Dimension Ltd.

Nano Dimension Ltd provide industrial manufacturing solutions for design-to-manufacturing of electronics and mechanical parts. These solutions are based on a combination of hardware, software, and materials science technologies. The solutions include industrial machinery, such as those for additive manufacturing, surface-mount technology, industrial inkjet printing, along with software for design, simulation, and manufacturing management, as well as materials or consumables that are used by the machinery. These solutions are used by industrial customers in aerospace & defense, automotive, electronics, medical, research and academia, along with government organizations.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Share on Social Networks: